FMS:NYE-Fresenius Medical Care AG (USD)

EQUITY | Medical Care Facilities | New York Stock Exchange

Last Closing

USD 22.97

Change

0.00 (0.00)%

Market Cap

USD 23.44B

Volume

0.23M

Analyst Target

USD 44.77
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Fresenius Medical Care AG & Co. KGaA is a kidney dialysis company, which is operating in both the field of dialysis products and dialysis services.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-28 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

-4.10 (-1.36%)

USD 76.91B
DVA DaVita HealthCare Partners Inc

-4.51 (-2.92%)

USD 12.66B
THC Tenet Healthcare Corporation

-2.55 (-1.99%)

USD 12.31B
UHS Universal Health Services Inc

-2.09 (-1.16%)

USD 11.60B
EHC Encompass Health Corp

-1.17 (-1.25%)

USD 9.52B
CHE Chemed Corp

+5.03 (+0.96%)

USD 7.84B
CON Concentra Group Holdings Paren..

-0.28 (-1.37%)

USD 2.93B
ARDT Ardent Health Partners, Inc.

-0.28 (-1.66%)

USD 2.59B
NHC National HealthCare Corporatio..

-2.20 (-2.01%)

USD 1.90B
BKD Brookdale Senior Living Inc

-0.13 (-2.56%)

USD 1.11B

ETFs Containing FMS

TPYP Tortoise North American P.. 3.85 % 0.40 %

+0.17 (+-0.88%)

N/A
RYU 3.37 % 0.40 %

N/A

N/A
TPHD Timothy Plan High Dividen.. 1.63 % 0.00 %

-0.17 (-0.88%)

USD 0.24B
TPHE Timothy Plan - Timothy Pl.. 1.62 % 0.00 %

-0.12 (-0.88%)

USD 0.07B
VRAI Virtus Real Asset Income .. 1.26 % 0.00 %

+0.08 (+-0.88%)

USD 0.01B
TPLE Timothy Plan - Timothy Pl.. 0.65 % 0.00 %

-0.23 (-0.88%)

USD 0.07B
TPLC Timothy Plan US Large/Mid.. 0.64 % 0.00 %

-0.31 (-0.88%)

USD 0.27B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.27% 52% F 63% D
Dividend Return 3.04% 80% B- 46% F
Total Return 13.32% 57% F 62% D
Trailing 12 Months  
Capital Gain 10.27% 52% F 63% D
Dividend Return 3.04% 80% B- 46% F
Total Return 13.32% 57% F 62% D
Trailing 5 Years  
Capital Gain -37.41% 22% F 15% F
Dividend Return 9.54% 88% B+ 29% F
Total Return -27.87% 28% F 13% F
Average Annual (5 Year Horizon)  
Capital Gain -13.41% 13% F 4% F
Dividend Return -10.95% 13% F 4% F
Total Return 2.46% 90% A- 56% F
Risk Return Profile  
Volatility (Standard Deviation) 26.48% 87% B+ 41% F
Risk Adjusted Return -41.35% 13% F 6% D-
Market Capitalization 23.44B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Care Facilities) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 20.30 N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector